表紙
市場調查報告書

頭孢菌素劑的全球市場:未來展望

Global Cephalosporin Drugs Market (2019-2025)

出版商 KBV Research 商品編碼 906238
出版日期 內容資訊 英文 300 Pages
訂單完成後即時交付
價格
Back to Top
頭孢菌素劑的全球市場:未來展望 Global Cephalosporin Drugs Market (2019-2025)
出版日期: 2019年07月31日內容資訊: 英文 300 Pages
簡介

本報告提供全球頭孢菌素劑的市場相關分析,彙整產品概要和市場主要趨勢,市場規模趨勢預測 (今後7年份),各用途·各類型及地區別詳細趨勢,主要的推動及阻礙市場要素,市場競爭環境,主要企業的簡介和策略展開情形等相關調查。

第1章 市場範圍和分析方法

第2章 市場概要

  • 簡介
  • 市場主要影響要素
    • 推動市場要素
    • 阻礙市場要素

第3章 全球頭孢菌素劑市場:各世代

  • 第1代
  • 第2代
  • 第3代
  • 第4代
  • 第5代

第4章 全球頭孢菌素劑市場:各用途

  • 呼吸道感染疾病
  • 皮膚感染疾病
  • 耳朵感染疾病
  • 性行為感染疾病
  • 其他

第5章 全球頭孢菌素劑市場:各給藥途徑

  • 注射藥
  • 口服藥

第6章 全球頭孢菌素劑市場:各類型

  • 品牌藥
  • 學名藥

第7章 全球頭孢菌素劑市場:各地區

  • 北美市場 (美國,加拿大,墨西哥等)
    • 各世代
    • 各用途
    • 各給藥途徑
    • 各類型
    • 各國分析
  • 歐洲市場 (德國,英國,法國,俄羅斯,西班牙,義大利等)
  • 亞太地區市場 (中國,日本,印度,韓國,新加坡,馬來西亞等)
  • 南美·中東·非洲市場 (LAMEA:巴西,阿根廷,UAE,沙烏地阿拉伯,南非,奈及利亞等)

第8章 企業簡介

  • ABBOTT Laboratories
    • 企業概要
    • 財務分析
    • 各領域·各地區分析
    • 研究開發 (R&D) 費用
    • 近幾年的策略展開趨勢
  • Teva Pharmaceutical Industries Ltd.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG (Bayer Schering Pharma AG)
  • Baxter International, Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG
目錄

The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.

A Cephalosporin Drugs is a group of semi-synthetic, wide-spectrum antibiotics mainly used to treat infections of bacteria. Increasing the incidence of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea are the main variables contributing to market growth. Increasing R&D operations to create extremely effective & secure medicines and increasing the use of combination therapies further enhance the growth of the market. Nevertheless, the side effects of Cephalosporin Drugs and the development of drug-resistant bacterial strains restrict the growth of the market.

Cephalosporin Drugss are categorized together based on the category of bacteria against which they are most efficient. These groups are known as generations. The global Cephalosporin Drugs market is witnessing growth due to an increase in infectious disease incidence, increased R&D operations for combination drug development, and increased financing for antibiotic development. Furthermore, increasing demand for the antibacterial drives the global Cephalosporin Drugs drug market to grow further.

Based on Generation, the market is segmented into First-Generation Cephalosporin, Second-Generation Cephalosporin, Third-Generation Cephalosporin, Fourth-Generation Cephalosporin, and Fifth-Generation Cephalosporin. Based on Application, the market is segmented into Respiratory Tract Infection, Skin Infection, Ear Infection, Sexually Transmitted Infection and Others. Based on Route of Administration, the market is segmented into Injections and Oral Drugs. Based on Type, the market is segmented into Branded and Generic. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Scope of the Study

Market Segmentation:

By Generation

  • First-Generation Cephalosporin
  • Second-Generation Cephalosporin
  • Third-Generation Cephalosporin
  • Fourth-Generation Cephalosporin
  • Fifth-Generation Cephalosporin

By Application

  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Sexually Transmitted Infection
  • Others

By Route of Administration

  • Injections
  • Oral Drugs

By Type

  • Branded
  • Generic

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled:

  • ABBOTT Laboratories
  • Teva Pharmaceuticals Industries Ltd.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Baxter International, Inc.
  • BRISTOL-MYERS SQUIBB COMPANY
  • Novartis AG

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cephalosporin Drugs Market, by Generation
    • 1.4.2 Global Cephalosporin Drugs Market, by Application
    • 1.4.3 Global Cephalosporin Drugs Market, by Route of Administration
    • 1.4.4 Global Cephalosporin Drugs Market, by Type
    • 1.4.5 Global Cephalosporin Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Cephalosporin Drugs Market by Generation

  • 3.1 Global First-Generation Cephalosporin Drugs Market by Region
  • 3.2 Global Second-Generation Cephalosporin Drugs Market by Region
  • 3.3 Global Third-Generation Cephalosporin Drugs Market by Region
  • 3.4 Global Fourth-Generation Cephalosporin Drugs Market by Region
  • 3.5 Global Fifth-Generation Cephalosporin Drugs Market by Region

Chapter 4. Global Cephalosporin Drugs Market by Application

  • 4.1 Global Respiratory Tract Infection Market by Region
  • 4.2 Global Skin Infection Market by Region
  • 4.3 Global Ear Infection Market by Region
  • 4.4 Global Sexually Transmitted Infection Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global Cephalosporin Drugs Market by Route of Administration

  • 5.1 Global Injections Market by Region
  • 5.2 Global Oral Drugs Market by Region

Chapter 6. Global Cephalosporin Drugs Market by Type

  • 6.1 Global Branded Market by Region
  • 6.2 Global Generic Market by Region

Chapter 7. Global Cephalosporin Drugs Market by Region

  • 7.1 North America Cephalosporin Drugs Market
    • 7.1.1 North America Cephalosporin Drugs Market by Generation
      • 7.1.1.1 North America First-Generation Cephalosporin Drugs Market by Country
      • 7.1.1.2 North America Second-Generation Cephalosporin Drugs Market by Country
      • 7.1.1.3 North America Third-Generation Cephalosporin Drugs Market by Country
      • 7.1.1.4 North America Fourth-Generation Cephalosporin Drugs Market by Country
      • 7.1.1.5 North America Fifth-Generation Cephalosporin Drugs Market by Country
    • 7.1.2 North America Cephalosporin Drugs Market by Application
      • 7.1.2.1 North America Respiratory Tract Infection Market by Country
      • 7.1.2.2 North America Skin Infection Market by Country
      • 7.1.2.3 North America Ear Infection Market by Country
      • 7.1.2.4 North America Sexually Transmitted Infection Market by Country
      • 7.1.2.5 North America Others Market by Country
    • 7.1.3 North America Cephalosporin Drugs Market by Route of Administration
      • 7.1.3.1 North America Injections Market by Country
      • 7.1.3.2 North America Oral Drugs Market by Country
    • 7.1.4 North America Cephalosporin Drugs Market by Type
      • 7.1.4.1 North America Branded Market by Country
      • 7.1.4.2 North America Generic Market by Country
    • 7.1.5 North America Cephalosporin Drugs Market by Country
      • 7.1.5.1 USA Cephalosporin Drugs Market
        • 7.1.5.1.1 USA Cephalosporin Drugs Market by Generation
        • 7.1.5.1.2 USA Cephalosporin Drugs Market by Application
        • 7.1.5.1.3 USA Cephalosporin Drugs Market by Route of Administration
        • 7.1.5.1.4 USA Cephalosporin Drugs Market by Type
      • 7.1.5.2 Canada Cephalosporin Drugs Market
        • 7.1.5.2.1 Canada Cephalosporin Drugs Market by Generation
        • 7.1.5.2.2 Canada Cephalosporin Drugs Market by Application
        • 7.1.5.2.3 Canada Cephalosporin Drugs Market by Route of Administration
        • 7.1.5.2.4 Canada Cephalosporin Drugs Market by Type
      • 7.1.5.3 Mexico Cephalosporin Drugs Market
        • 7.1.5.3.1 Mexico Cephalosporin Drugs Market by Generation
        • 7.1.5.3.2 Mexico Cephalosporin Drugs Market by Application
        • 7.1.5.3.3 Mexico Cephalosporin Drugs Market by Route of Administration
        • 7.1.5.3.4 Mexico Cephalosporin Drugs Market by Type
      • 7.1.5.4 Rest of North America Cephalosporin Drugs Market
        • 7.1.5.4.1 Rest of North America Cephalosporin Drugs Market by Generation
        • 7.1.5.4.2 Rest of North America Cephalosporin Drugs Market by Application
        • 7.1.5.4.3 Rest of North America Cephalosporin Drugs Market by Route of Administration
        • 7.1.5.4.4 Rest of North America Cephalosporin Drugs Market by Type
  • 7.2 Europe Cephalosporin Drugs Market
    • 7.2.1 Europe Cephalosporin Drugs Market by Generation
      • 7.2.1.1 Europe First-Generation Cephalosporin Drugs Market by Country
      • 7.2.1.2 Europe Second-Generation Cephalosporin Drugs Market by Country
      • 7.2.1.3 Europe Third-Generation Cephalosporin Drugs Market by Country
      • 7.2.1.4 Europe Fourth-Generation Cephalosporin Drugs Market by Country
      • 7.2.1.5 Europe Fifth-Generation Cephalosporin Drugs Market by Country
    • 7.2.2 Europe Cephalosporin Drugs Market by Application
      • 7.2.2.1 Europe Respiratory Tract Infection Market by Country
      • 7.2.2.2 Europe Skin Infection Market by Country
      • 7.2.2.3 Europe Ear Infection Market by Country
      • 7.2.2.4 Europe Sexually Transmitted Infection Market by Country
      • 7.2.2.5 Europe Others Market by Country
    • 7.2.3 Europe Cephalosporin Drugs Market by Route of Administration
      • 7.2.3.1 Europe Injections Market by Country
      • 7.2.3.2 Europe Oral Drugs Market by Country
    • 7.2.4 Europe Cephalosporin Drugs Market by Type
      • 7.2.4.1 Europe Branded Market by Country
      • 7.2.4.2 Europe Generic Market by Country
    • 7.2.5 Europe Cephalosporin Drugs Market by Country
      • 7.2.5.1 Germany Cephalosporin Drugs Market
        • 7.2.5.1.1 Germany Cephalosporin Drugs Market by Generation
        • 7.2.5.1.2 Germany Cephalosporin Drugs Market by Application
        • 7.2.5.1.3 Germany Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.1.4 Germany Cephalosporin Drugs Market by Type
      • 7.2.5.2 UK Cephalosporin Drugs Market
        • 7.2.5.2.1 UK Cephalosporin Drugs Market by Generation
        • 7.2.5.2.2 UK Cephalosporin Drugs Market by Application
        • 7.2.5.2.3 UK Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.2.4 UK Cephalosporin Drugs Market by Type
      • 7.2.5.3 France Cephalosporin Drugs Market
        • 7.2.5.3.1 France Cephalosporin Drugs Market by Generation
        • 7.2.5.3.2 France Cephalosporin Drugs Market by Application
        • 7.2.5.3.3 France Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.3.4 France Cephalosporin Drugs Market by Type
      • 7.2.5.4 Russia Cephalosporin Drugs Market
        • 7.2.5.4.1 Russia Cephalosporin Drugs Market by Generation
        • 7.2.5.4.2 Russia Cephalosporin Drugs Market by Application
        • 7.2.5.4.3 Russia Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.4.4 Russia Cephalosporin Drugs Market by Type
      • 7.2.5.5 Spain Cephalosporin Drugs Market
        • 7.2.5.5.1 Spain Cephalosporin Drugs Market by Generation
        • 7.2.5.5.2 Spain Cephalosporin Drugs Market by Application
        • 7.2.5.5.3 Spain Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.5.4 Spain Cephalosporin Drugs Market by Type
      • 7.2.5.6 Italy Cephalosporin Drugs Market
        • 7.2.5.6.1 Italy Cephalosporin Drugs Market by Generation
        • 7.2.5.6.2 Italy Cephalosporin Drugs Market by Application
        • 7.2.5.6.3 Italy Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.6.4 Italy Cephalosporin Drugs Market by Type
      • 7.2.5.7 Rest of Europe Cephalosporin Drugs Market
        • 7.2.5.7.1 Rest of Europe Cephalosporin Drugs Market by Generation
        • 7.2.5.7.2 Rest of Europe Cephalosporin Drugs Market by Application
        • 7.2.5.7.3 Rest of Europe Cephalosporin Drugs Market by Route of Administration
        • 7.2.5.7.4 Rest of Europe Cephalosporin Drugs Market by Type
  • 7.3 Asia Pacific Cephalosporin Drugs Market
    • 7.3.1 Asia Pacific Cephalosporin Drugs Market by Generation
      • 7.3.1.1 Asia Pacific First-Generation Cephalosporin Drugs Market by Country
      • 7.3.1.2 Asia Pacific Second-Generation Cephalosporin Drugs Market by Country
      • 7.3.1.3 Asia Pacific Third-Generation Cephalosporin Drugs Market by Country
      • 7.3.1.4 Asia Pacific Fourth-Generation Cephalosporin Drugs Market by Country
      • 7.3.1.5 Asia Pacific Fifth-Generation Cephalosporin Drugs Market by Country
    • 7.3.2 Asia Pacific Cephalosporin Drugs Market by Application
      • 7.3.2.1 Asia Pacific Respiratory Tract Infection Market by Country
      • 7.3.2.2 Asia Pacific Skin Infection Market by Country
      • 7.3.2.3 Asia Pacific Ear Infection Market by Country
      • 7.3.2.4 Asia Pacific Sexually Transmitted Infection Market by Country
      • 7.3.2.5 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Cephalosporin Drugs Market by Route of Administration
      • 7.3.3.1 Asia Pacific Injections Market by Country
      • 7.3.3.2 Asia Pacific Oral Drugs Market by Country
    • 7.3.4 Asia Pacific Cephalosporin Drugs Market by Type
      • 7.3.4.1 Asia Pacific Branded Market by Country
      • 7.3.4.2 Asia Pacific Generic Market by Country
    • 7.3.5 Asia Pacific Cephalosporin Drugs Market by Country
      • 7.3.5.1 China Cephalosporin Drugs Market
        • 7.3.5.1.1 China Cephalosporin Drugs Market by Generation
        • 7.3.5.1.2 China Cephalosporin Drugs Market by Application
        • 7.3.5.1.3 China Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.1.4 China Cephalosporin Drugs Market by Type
      • 7.3.5.2 Japan Cephalosporin Drugs Market
        • 7.3.5.2.1 Japan Cephalosporin Drugs Market by Generation
        • 7.3.5.2.2 Japan Cephalosporin Drugs Market by Application
        • 7.3.5.2.3 Japan Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.2.4 Japan Cephalosporin Drugs Market by Type
      • 7.3.5.3 India Cephalosporin Drugs Market
        • 7.3.5.3.1 India Cephalosporin Drugs Market by Generation
        • 7.3.5.3.2 India Cephalosporin Drugs Market by Application
        • 7.3.5.3.3 India Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.3.4 India Cephalosporin Drugs Market by Type
      • 7.3.5.4 South Korea Cephalosporin Drugs Market
        • 7.3.5.4.1 South Korea Cephalosporin Drugs Market by Generation
        • 7.3.5.4.2 South Korea Cephalosporin Drugs Market by Application
        • 7.3.5.4.3 South Korea Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.4.4 South Korea Cephalosporin Drugs Market by Type
      • 7.3.5.5 Singapore Cephalosporin Drugs Market
        • 7.3.5.5.1 Singapore Cephalosporin Drugs Market by Generation
        • 7.3.5.5.2 Singapore Cephalosporin Drugs Market by Application
        • 7.3.5.5.3 Singapore Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.5.4 Singapore Cephalosporin Drugs Market by Type
      • 7.3.5.6 Malaysia Cephalosporin Drugs Market
        • 7.3.5.6.1 Malaysia Cephalosporin Drugs Market by Generation
        • 7.3.5.6.2 Malaysia Cephalosporin Drugs Market by Application
        • 7.3.5.6.3 Malaysia Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.6.4 Malaysia Cephalosporin Drugs Market by Type
      • 7.3.5.7 Rest of Asia Pacific Cephalosporin Drugs Market
        • 7.3.5.7.1 Rest of Asia Pacific Cephalosporin Drugs Market by Generation
        • 7.3.5.7.2 Rest of Asia Pacific Cephalosporin Drugs Market by Application
        • 7.3.5.7.3 Rest of Asia Pacific Cephalosporin Drugs Market by Route of Administration
        • 7.3.5.7.4 Rest of Asia Pacific Cephalosporin Drugs Market by Type
  • 7.4 LAMEA Cephalosporin Drugs Market
    • 7.4.1 LAMEA Cephalosporin Drugs Market by Generation
      • 7.4.1.1 LAMEA First-Generation Cephalosporin Drugs Market by Country
      • 7.4.1.2 LAMEA Second-Generation Cephalosporin Drugs Market by Country
      • 7.4.1.3 LAMEA Third-Generation Cephalosporin Drugs Market by Country
      • 7.4.1.4 LAMEA Fourth-Generation Cephalosporin Drugs Market by Country
      • 7.4.1.5 LAMEA Fifth-Generation Cephalosporin Drugs Market by Country
    • 7.4.2 LAMEA Cephalosporin Drugs Market by Application
      • 7.4.2.1 LAMEA Respiratory Tract Infection Market by Country
      • 7.4.2.2 LAMEA Skin Infection Market by Country
      • 7.4.2.3 LAMEA Ear Infection Market by Country
      • 7.4.2.4 LAMEA Sexually Transmitted Infection Market by Country
      • 7.4.2.5 LAMEA Others Market by Country
    • 7.4.3 LAMEA Cephalosporin Drugs Market by Route of Administration
      • 7.4.3.1 LAMEA Injections Market by Country
      • 7.4.3.2 LAMEA Oral Drugs Market by Country
    • 7.4.4 LAMEA Cephalosporin Drugs Market by Type
      • 7.4.4.1 LAMEA Branded Market by Country
      • 7.4.4.2 LAMEA Generic Market by Country
    • 7.4.5 LAMEA Cephalosporin Drugs Market by Country
      • 7.4.5.1 Brazil Cephalosporin Drugs Market
        • 7.4.5.1.1 Brazil Cephalosporin Drugs Market by Generation
        • 7.4.5.1.2 Brazil Cephalosporin Drugs Market by Application
        • 7.4.5.1.3 Brazil Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.1.4 Brazil Cephalosporin Drugs Market by Type
      • 7.4.5.2 Argentina Cephalosporin Drugs Market
        • 7.4.5.2.1 Argentina Cephalosporin Drugs Market by Generation
        • 7.4.5.2.2 Argentina Cephalosporin Drugs Market by Application
        • 7.4.5.2.3 Argentina Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.2.4 Argentina Cephalosporin Drugs Market by Type
      • 7.4.5.3 UAE Cephalosporin Drugs Market
        • 7.4.5.3.1 UAE Cephalosporin Drugs Market by Generation
        • 7.4.5.3.2 UAE Cephalosporin Drugs Market by Application
        • 7.4.5.3.3 UAE Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.3.4 UAE Cephalosporin Drugs Market by Type
      • 7.4.5.4 Saudi Arabia Cephalosporin Drugs Market
        • 7.4.5.4.1 Saudi Arabia Cephalosporin Drugs Market by Generation
        • 7.4.5.4.2 Saudi Arabia Cephalosporin Drugs Market by Application
        • 7.4.5.4.3 Saudi Arabia Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.4.4 Saudi Arabia Cephalosporin Drugs Market by Type
      • 7.4.5.5 South Africa Cephalosporin Drugs Market
        • 7.4.5.5.1 South Africa Cephalosporin Drugs Market by Generation
        • 7.4.5.5.2 South Africa Cephalosporin Drugs Market by Application
        • 7.4.5.5.3 South Africa Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.5.4 South Africa Cephalosporin Drugs Market by Type
      • 7.4.5.6 Nigeria Cephalosporin Drugs Market
        • 7.4.5.6.1 Nigeria Cephalosporin Drugs Market by Generation
        • 7.4.5.6.2 Nigeria Cephalosporin Drugs Market by Application
        • 7.4.5.6.3 Nigeria Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.6.4 Nigeria Cephalosporin Drugs Market by Type
      • 7.4.5.7 Rest of LAMEA Cephalosporin Drugs Market
        • 7.4.5.7.1 Rest of LAMEA Cephalosporin Drugs Market by Generation
        • 7.4.5.7.2 Rest of LAMEA Cephalosporin Drugs Market by Application
        • 7.4.5.7.3 Rest of LAMEA Cephalosporin Drugs Market by Route of Administration
        • 7.4.5.7.4 Rest of LAMEA Cephalosporin Drugs Market by Type

Chapter 8. Company Profiles

  • 8.1 ABBOTT Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.1 Recent strategies and developments:
      • 8.1.1.1 Collaborations, partnerships and agreements:
      • 8.1.1.2 Acquisition and Mergers:
  • 8.2 Teva Pharmaceutical Industries Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product launches:
  • 8.3 Johnson and Johnson
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental &Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Acquisition and Mergers:
  • 8.4 GlaxoSmithKline PLC (GSK)
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Collaborations, partnerships and agreements:
      • 8.4.5.2 Expansion:
      • 8.4.5.3 Approval:
  • 8.5 Pfizer, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Collaborations, partnerships and agreements:
      • 8.5.5.2 Product launches:
      • 8.5.5.3 Acquisition and Mergers:
  • 8.6 Merck & Co., Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Collaborations, partnerships and agreements:
      • 8.6.5.2 Product launches:
  • 8.7 Bayer AG (Bayer Schering Pharma AG)
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Collaborations, partnerships and agreements:
      • 8.7.5.2 Product launches:
  • 8.8 Baxter International, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Product launches:
  • 8.9 Bristol-Myers Squibb Company
    • 8.9.1 Company overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Collaborations, partnerships and agreements:
  • 8.1 Novartis AG
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Product launches:
      • 8.10.5.2 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1: GLOBAL CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 3: GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL RESPIRATORY TRACT INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL SKIN INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL SKIN INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL EAR INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL EAR INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL SEXUALLY TRANSMITTED INFECTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL INJECTIONS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL INJECTIONS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL ORAL DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL ORAL DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 34: GLOBAL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 35: GLOBAL BRANDED MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 36: GLOBAL BRANDED MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 37: GLOBAL GENERIC MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 38: GLOBAL GENERIC MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 39: GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 40: GLOBAL CEPHALOSPORIN DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 41: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 42: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 65: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 66: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 67: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 68: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 69: NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 70: NORTH AMERICA INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 71: NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 72: NORTH AMERICA ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 73: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 74: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 75: NORTH AMERICA BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 76: NORTH AMERICA BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 77: NORTH AMERICA GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 78: NORTH AMERICA GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 79: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 80: NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 81: USA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 82: USA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 83: USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 84: USA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 85: USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 86: USA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 87: USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 88: USA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 89: USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 90: USA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 91: CANADA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 92: CANADA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 93: CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 94: CANADA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 95: CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 96: CANADA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 97: CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 98: CANADA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 99: CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 100: CANADA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 101: MEXICO CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 102: MEXICO CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 103: MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 104: MEXICO CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 105: MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 106: MEXICO CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 107: MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 108: MEXICO CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 109: MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 110: MEXICO CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 111: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 112: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 113: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 114: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 115: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 116: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 117: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 118: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 119: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 120: REST OF NORTH AMERICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 121: EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 122: EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 123: EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 124: EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 125: EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 126: EUROPE FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 127: EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 128: EUROPE SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 129: EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 130: EUROPE THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 131: EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 132: EUROPE FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 133: EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 134: EUROPE FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 135: EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 136: EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 137: EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 138: EUROPE RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 139: EUROPE SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 140: EUROPE SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 141: EUROPE EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 142: EUROPE EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 143: EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 144: EUROPE SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 145: EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 146: EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 147: EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 148: EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 149: EUROPE INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 150: EUROPE INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 151: EUROPE ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 152: EUROPE ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 153: EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 154: EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 155: EUROPE BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 156: EUROPE BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 157: EUROPE GENERIC MARKET BY COUNTRY, 2015 - 2018,USD MILLION
  • TABLE 158: EUROPE GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 159: EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 160: EUROPE CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 161: GERMANY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 162: GERMANY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 163: GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 164: GERMANY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 165: GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 166: GERMANY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 167: GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 168: GERMANY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 169: GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 170: GERMANY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 171: UK CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 172: UK CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 173: UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 174: UK CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 175: UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 176: UK CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 177: UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 178: UK CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 179: UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 180: UK CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 181: FRANCE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 182: FRANCE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 183: FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 184: FRANCE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 185: FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 186: FRANCE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 187: FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 188: FRANCE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 189: FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 190: FRANCE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 191: RUSSIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 192: RUSSIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 193: RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 194: RUSSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 195: RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 196: RUSSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 197: RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 198: RUSSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 199: RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 200: RUSSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 201: SPAIN CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 202: SPAIN CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 203: SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 204: SPAIN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 205: SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 206: SPAIN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 207: SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 208: SPAIN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 209: SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 210: SPAIN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 211: ITALY CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 212: ITALY CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 213: ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 214: ITALY CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 215: ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 216: ITALY CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 217: ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 218: ITALY CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 219: ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 220: ITALY CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 221: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 222: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 223: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 224: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 225: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 226: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 227: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 228: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 229: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 230: REST OF EUROPE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 231: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 232: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 233: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 234: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 235: ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 236: ASIA PACIFIC FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 237: ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 238: ASIA PACIFIC SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 239: ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 240: ASIA PACIFIC THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 241: ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 242: ASIA PACIFIC FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 243: ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 244: ASIA PACIFIC FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 245: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 246: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 247: ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 248: ASIA PACIFIC RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 249: ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 250: ASIA PACIFIC SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 251: ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 252: ASIA PACIFIC EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 253: ASIA PACIFIC SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 254: ASIA PACIFIC SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 255: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 256: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 257: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 258: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 259: ASIA PACIFIC INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 260: ASIA PACIFIC INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 261: ASIA PACIFIC ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 262: ASIA PACIFIC ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 263: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 264: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 265: ASIA PACIFIC BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 266: ASIA PACIFIC BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 267: ASIA PACIFIC GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 268: ASIA PACIFIC GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 269: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 270: ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 271: CHINA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 272: CHINA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 273: CHINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 274: CHINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 275: CHINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 276: CHINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 277: CHINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 278: CHINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 279: CHINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 280: CHINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 281: JAPAN CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 282: JAPAN CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 283: JAPAN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 284: JAPAN CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 285: JAPAN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 286: JAPAN CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 287: JAPAN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 288: JAPAN CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 289: JAPAN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 290: JAPAN CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 291: INDIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 292: INDIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 293: INDIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 294: INDIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 295: INDIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 296: INDIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 297: INDIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 298: INDIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 299: INDIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 300: INDIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 301: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 302: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 303: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 304: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 305: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 306: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 307: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 308: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 309: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 310: SOUTH KOREA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 311: SINGAPORE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 312: SINGAPORE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 313: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 314: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 315: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 316: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 317: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 318: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 319: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 320: SINGAPORE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 321: MALAYSIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 322: MALAYSIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 323: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 324: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 325: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 326: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 327: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 328: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 329: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 330: MALAYSIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 331: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 332: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 333: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 334: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 335: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 336: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 337: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 338: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 339: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 340: REST OF ASIA PACIFIC CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 341: LAMEA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 342: LAMEA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 343: LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 344: LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 345: LAMEA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 346: LAMEA FIRST-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 347: LAMEA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 348: LAMEA SECOND-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 349: LAMEA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 350: LAMEA THIRD-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 351: LAMEA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 352: LAMEA FOURTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 353: LAMEA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 354: LAMEA FIFTH-GENERATION CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 355: LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 356: LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 357: LAMEA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 358: LAMEA RESPIRATORY TRACT INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 359: LAMEA SKIN INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 360: LAMEA SKIN INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 361: LAMEA EAR INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 362: LAMEA EAR INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 363: LAMEA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 364: LAMEA SEXUALLY TRANSMITTED INFECTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 365: LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 366: LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 367: LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 368: LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 369: LAMEA INJECTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 370: LAMEA INJECTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 371: LAMEA ORAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 372: LAMEA ORAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 373: LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 374: LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 375: LAMEA BRANDED MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 376: LAMEA BRANDED MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 377: LAMEA GENERIC MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 378: LAMEA GENERIC MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 379: LAMEA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 380: LAMEA CEPHALOSPORIN DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 381: BRAZIL CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 382: BRAZIL CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 383: BRAZIL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 384: BRAZIL CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 385: BRAZIL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 386: BRAZIL CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 387: BRAZIL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 388: BRAZIL CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 389: BRAZIL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 390: BRAZIL CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 391: ARGENTINA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 392: ARGENTINA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 393: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 394: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 395: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 396: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 397: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 398: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 399: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 400: ARGENTINA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 401: UAE CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 402: UAE CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 403: UAE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 404: UAE CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 405: UAE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 406: UAE CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 407: UAE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 408: UAE CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 409: UAE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 410: UAE CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 411: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 412: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 413: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 414: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 415: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 416: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 417: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 418: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 419: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 420: SAUDI ARABIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 421: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 422: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 423: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 424: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 425: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 426: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 427: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 428: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 429: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 430: SOUTH AFRICA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 431: NIGERIA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 432: NIGERIA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 433: NIGERIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 434: NIGERIA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 435: NIGERIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 436: NIGERIA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 437: NIGERIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 438: NIGERIA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 439: NIGERIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 440: NIGERIA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 441: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET, 2015 - 2018, USD MILLION
  • TABLE 442: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET, 2019 - 2025, USD MILLION
  • TABLE 443: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2015 - 2018, USD MILLION
  • TABLE 444: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY GENERATION, 2019 - 2025, USD MILLION
  • TABLE 445: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 446: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 447: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2015 - 2018, USD MILLION
  • TABLE 448: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2019 - 2025, USD MILLION
  • TABLE 449: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 450: REST OF LAMEA CEPHALOSPORIN DRUGS MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 451: KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 452: KEY INFORMATION - TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • TABLE 453: KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 454: KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 455: KEY INFORMATION - PFIZER, INC.
  • TABLE 456: KEY INFORMATION - MERCK & CO., INC.
  • TABLE 457: KEY INFORMATION - BAYER AG
  • TABLE 458: KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 459: KEY INFORMATION - BRISTOL-MYERS SQUIBB COMPANY
  • TABLE 460: KEY INFORMATION - NOVARTIS AG

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
Back to Top